Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2017, Article ID 8916570, 14 pages
https://doi.org/10.1155/2017/8916570
Review Article

Mesenchymal Stem Cell Administration in Patients with Chronic Obstructive Pulmonary Disease: State of the Science

1Department of Internal Medicine, Far Eastern Memorial Hospital, Taipei, Taiwan
2Department of Chemical Engineering and Materials Science, Yuan Ze University, Chung-Li District, Taoyuan City, Taiwan
3Division of Chest Medicine, Changhua Christian Hospital, Changhua, Taiwan

Correspondence should be addressed to Ching-Hsiung Lin; wt.gro.hcc@22874 and Chao-Ling Yao; wt.ude.uhtn.inmula@106798d

Received 3 November 2016; Accepted 22 January 2017; Published 20 February 2017

Academic Editor: Ying Liu

Copyright © 2017 Shih-Lung Cheng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, Global Surveillance, Prevention and Control of Chronic Respiratory Diseases: A Comprehensive Approach, Edited by J. Bousquet and N. Khaltaev, World Health Organization, Geneva, Switzerland, 2007, http://apps.who.int/iris/bitstream/10665/43776/1/9789241563468_eng.pdf.
  2. P. J. Barnes, “Chronic obstructive pulmonary disease,” New England Journal of Medicine, vol. 343, no. 4, pp. 269–280, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. A. M. Katsha, S. Ohkouchi, H. Xin et al., “Paracrine factors of multipotent stromal cells ameliorate lung injury in an elastase-induced emphysema model,” Molecular Therapy, vol. 19, no. 1, pp. 196–203, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Gupta, X. Su, B. Popov, W. L. Jae, V. Serikov, and M. A. Matthay, “Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice,” Journal of Immunology, vol. 179, no. 3, pp. 1855–1863, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. S. S. Iyer and M. Rojas, “Anti-inflammatory effects of mesenchymal stem cells: novel concept for future therapies,” Expert Opinion on Biological Therapy, vol. 8, no. 5, pp. 569–581, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Krampera, A. Pasini, G. Pizzolo, L. Cosmi, S. Romagnani, and F. Annunziato, “Regenerative and immunomodulatory potential of mesenchymal stem cells,” Current Opinion in Pharmacology, vol. 6, no. 4, pp. 435–441, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. D. J. Weiss, J. K. Kolls, L. A. Ortiz, A. Panoskaltsis-Mortari, and D. J. Prockop, “Stem cells and cell therapies in lung biology and lung diseases,” Proceedings of the American Thoracic Society, vol. 5, no. 5, pp. 637–667, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Shigemura, M. Okumura, S. Mizuno et al., “Lung tissue engineering technique with adipose stromal cells improves surgical outcome for pulmonary emphysema,” American Journal of Respiratory and Critical Care Medicine, vol. 174, no. 11, pp. 1199–1205, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Zhen, Z. Xue, J. Zhao et al., “Mesenchymal stem cell transplantation increases expression of vascular endothelial growth factor in papain-induced emphysematous lungs and inhibits apoptosis of lung cells,” Cytotherapy, vol. 12, no. 5, pp. 605–614, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. X. Liu, Q. Fang, and H. Kim, “Preclinical studies of mesenchymal stem cell (MSC) administration in chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis,” PLoS ONE, vol. 11, no. 6, Article ID e0157099, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. T. J. Kean, P. Lin, A. I. Caplan, and J. E. Dennis, “MSCs: delivery routes and engraftment, cell-targeting strategies, and immune modulation,” Stem Cells International, vol. 2013, Article ID 732742, 13 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Dominici, K. Le Blanc, I. Mueller et al., “Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement,” Cytotherapy, vol. 8, no. 4, pp. 315–317, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Galipeau, M. Krampera, J. Barrett et al., “International society for cellular therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials,” Cytotherapy, vol. 18, no. 2, pp. 151–159, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Krampera, J. Galipeau, Y. Shi, K. Tarte, and L. Sensebe, “Immunological characterization of multipotent mesenchymal stromal cells—the international society for cellular therapy (ISCT) working proposal,” Cytotherapy, vol. 15, no. 9, pp. 1054–1061, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. I. Martin, J. De Boer, and L. Sensebe, “A relativity concept in mesenchymal stromal cell manufacturing,” Cytotherapy, vol. 18, no. 5, pp. 613–620, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. D. G. Phinney and L. Sensebé, “Mesenchymal stromal cells: misconceptions and evolving concepts,” Cytotherapy, vol. 15, no. 2, pp. 140–145, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. D. G. Phinney, J. Galipeau, M. Krampera, I. Martin, Y. Shi, and L. Sensebe, “MSCs: science and trials,” Nature Medicine, vol. 19, no. 7, article no. 812, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Sensebé, K. Tarte, J. Galipeau et al., “Limited acquisition of chromosomal aberrations in human adult mesenchymal stromal cells,” Cell Stem Cell, vol. 10, no. 1, pp. 9–10, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. K. M. Akram, N. Patel, M. A. Spiteri, and N. R. Forsyth, “Lung regeneration: endogenous and exogenous stem cell mediated therapeutic approaches,” International Journal of Molecular Sciences, vol. 17, no. 1, article 128, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Conese, A. Carbone, S. Castellani, and S. Di Gioia, “Paracrine effects and heterogeneity of marrow-derived stem/progenitor cells: relevance for the treatment of respiratory diseases,” Cells Tissues Organs, vol. 197, no. 6, pp. 445–473, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Conese, D. Piro, A. Carbone, S. Castellani, and S. Di Gioia, “Hematopoietic and mesenchymal stem cells for the treatment of chronic respiratory diseases: role of plasticity and heterogeneity,” The Scientific World Journal, vol. 2014, Article ID 859817, 11 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. M. D. Griffin, S. J. Elliman, E. Cahill, K. English, R. Ceredig, and T. Ritter, “Concise review: adult mesenchymal stromal cell therapy for inflammatory diseases: how well are we joining the dots?” Stem Cells, vol. 31, no. 10, pp. 2033–2041, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. Z. Jin, X. Pan, K. Zhou et al., “Biological effects and mechanisms of action of mesenchymal stem cell therapy in chronic obstructive pulmonary disease,” Journal of International Medical Research, vol. 43, no. 3, pp. 303–310, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Lipsi, P. Rogliani, L. Calzetta, A. Segreti, and M. Cazzola, “The clinical use of regenerative therapy in COPD,” International Journal of COPD, vol. 9, pp. 1389–1396, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Mercado, K. Ito, and P. J. Barnes, “Accelerated ageing of the lung in COPD: new concepts,” Thorax, vol. 70, no. 5, pp. 482–489, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. O. Ojo, A. L. Lagan, V. Rajendran et al., “Pathological changes in the COPD lung mesenchyme—novel lessons learned from in vitro and in vivo studies,” Pulmonary Pharmacology & Therapeutics, vol. 29, no. 2, pp. 121–128, 2014. View at Publisher · View at Google Scholar
  27. C. O'Leary, J. L. Gilbert, S. O'Dea, F. J. O'Brien, and S.-A. Cryan, “Respiratory tissue engineering: current status and opportunities for the future,” Tissue Engineering—Part B: Reviews, vol. 21, no. 4, pp. 323–344, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. D. J. Weiss, “Concise review: current status of stem cells and regenerative medicine in lung biology and diseases,” Stem Cells, vol. 32, no. 1, pp. 16–25, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. S.-R. Yang, J.-R. Park, and K.-S. Kang, “Reactive oxygen species in mesenchymal stem cell aging: implication to lung diseases,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 486263, 11 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. J. D. Silva, B. D. Paredes, I. M. Araújo et al., “Effects of bone marrow-derived mononuclear cells from healthy or acute respiratory distress syndrome donors on recipient lung-injured Mice,” Critical Care Medicine, vol. 42, no. 7, pp. e510–e524, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. J. T. Ribeiro-Paes, A. Bilaqui, O. T. Greco et al., “Unicentric study of cell therapy in chronic obstructive pulmonary disease/pulmonary emphysema,” International Journal of COPD, vol. 6, no. 1, pp. 63–71, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Slowman, C. Danielson, V. Graves, P. Kotylo, R. Broun, and L. McCarthy, “Administration of GM-/G-CSF prior to bone marrow harvest increases collection of CD34+ cells,” Progress in Clinical and Biological Research, vol. 389, pp. 363–369, 1994. View at Google Scholar · View at Scopus
  33. K. A. Dicke, D. L. Hood, M. Arneson et al., “Effects of short-term in vivo administration of G-CSF on bone marrow prior to harvesting,” Experimental Hematology, vol. 25, no. 1, pp. 34–38, 1997. View at Google Scholar · View at Scopus
  34. L. M. Isola, E. Scigliano, D. Skerrett et al., “A pilot study of allogeneic bone marrow transplantation using related donors stimulated with G-CSF,” Bone Marrow Transplantation, vol. 20, no. 12, pp. 1033–1037, 1997. View at Publisher · View at Google Scholar · View at Scopus
  35. E. Dahl, J. Burroughs, T. DeFor, C. Verfaillie, and D. Weisdorf, “Progenitor content of autologous grafts: mobilized bone marrow vs mobilized blood,” Bone Marrow Transplantation, vol. 32, no. 6, pp. 575–580, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. J.-P. Levesque and I. G. Winkler, “Mobilization of hematopoietic stem cells: state of the art,” Current Opinion in Organ Transplantation, vol. 13, no. 1, pp. 53–58, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Frangoul, E. R. Nemecek, D. Billheimer et al., “A prospective study of G-CSF-primed bone marrow as a stem-cell source for allogeneic bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium (PBMTC) study,” Blood, vol. 110, no. 13, pp. 4584–4587, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. H. T. Greinix and N. Worel, “New agents for mobilizing peripheral blood stem cells,” Transfusion and Apheresis Science, vol. 41, no. 1, pp. 67–71, 2009. View at Publisher · View at Google Scholar
  39. M. Hokari, S. Kuroda, Y. Chiba, K. Maruichi, and Y. Iwasaki, “Synergistic effects of granulocyte-colony stimulating factor on bone marrow stromal cell transplantation for mice cerebral infarct,” Cytokine, vol. 46, no. 2, pp. 260–266, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. I. Pusic and J. F. DiPersio, “The use of growth factors in hematopoietic stem cell transplantation,” Current Pharmaceutical Design, vol. 14, no. 20, pp. 1950–1961, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. R. S. Ripa, E. Jørgensen, Y. Wang et al., “Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial,” Circulation, vol. 113, no. 16, pp. 1983–1992, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. A. C. Zubair, S. Malik, A. Paulsen et al., “Evaluation of mobilized peripheral blood CD34+ cells from patients with severe coronary artery disease as a source of endothelial progenitor cells,” Cytotherapy, vol. 12, no. 2, pp. 178–189, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. H. E. Johnsen, L. Jensen, E. Gaarsdal, P. B. Hansen, J. Ersboll, and N. E. Hansen, “Priming with recombinant human hematopoietic cytokines before bone marrow harvest expands in vivo and enhances ex vivo recovery of myeloid progenitors in short-term liquid cultures,” Experimental Hematology, vol. 22, no. 1, pp. 80–86, 1994. View at Google Scholar · View at Scopus
  44. H. Jin, A. Aiyer, J. Su et al., “A homing mechanism for bone marrow-derived progenitor cell recruitment to the neovasculature,” Journal of Clinical Investigation, vol. 116, no. 3, pp. 652–662, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. D. Mizrak, M. Brittan, and M. R. Alison, “CD 133: molecule of the moment,” Journal of Pathology, vol. 214, no. 1, pp. 3–9, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Huertas, U. Testa, R. Riccioni et al., “Bone marrow-derived progenitors are greatly reduced in patients with severe COPD and low-BMI,” Respiratory Physiology and Neurobiology, vol. 170, no. 1, pp. 23–31, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Mehta, “Cytokines in hematopoietic stem cell transplantation,” Cancer Treatment and Research, vol. 126, pp. 333–351, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. T. Stessuk, M. A. Ruiz, O. T. Greco, A. Bilaqui, M. J. D. O. Ribeiro-Paes, and J. T. Ribeiro-Paes, “Phase I clinical trial of cell therapy in patients with advanced chronic obstructive pulmonary disease: follow-up of up to 3 years,” Revista Brasileira de Hematologia e Hemoterapia, vol. 35, no. 5, pp. 352–357, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. D. J. Weiss, R. Casaburi, R. Flannery, M. LeRoux-Williams, and D. P. Tashkin, “A placebo-controlled, randomized trial of mesenchymal stem cells in COPD,” Chest, vol. 143, no. 6, pp. 1590–1598, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Stolk, W. Broekman, T. Mauad et al., “A phase I study for intravenous autologous mesenchymal stromal cell administration to patients with severe emphysema,” QJM, vol. 109, no. 5, pp. 331–336, 2016. View at Publisher · View at Google Scholar · View at Scopus
  51. P. Gentile, M. G. Scioli, A. Bielli, A. Orlandi, and V. Cervelli, “Concise review: the use of adipose-derived stromal vascular fraction cells and platelet rich plasma in regenerative plastic surgery,” Stem Cells, vol. 35, no. 1, pp. 117–134, 2017. View at Google Scholar
  52. K. S. Schweitzer, B. H. Johnstone, J. Garrison et al., “Adipose stem cell treatment in mice attenuates lung and systemic injury induced by cigarette smoking,” American Journal of Respiratory and Critical Care Medicine, vol. 183, no. 2, pp. 215–225, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Tobita, S. Tajima, and H. Mizuno, “Adipose tissue-derived mesenchymal stem cells and platelet-rich plasma: stem cell transplantation methods that enhance stemness,” Stem Cell Research and Therapy, vol. 6, no. 1, article no. 215, 2015. View at Publisher · View at Google Scholar · View at Scopus
  54. Q. Li, A. Zhang, C. Tao, X. Li, and P. Jin, “The role of SDF-1-CXCR4/CXCR7 axis in biological behaviors of adipose tissue-derived mesenchymal stem cells in vitro,” Biochemical and Biophysical Research Communications, vol. 441, no. 3, pp. 675–680, 2013. View at Publisher · View at Google Scholar · View at Scopus
  55. A. M. Sharifi, R. Ghazanfari, N. Tekiyehmaroof, and M. A. Sharifi, “Isolation, cultivation, characterization and expansion of human adipose-derived mesenchymal stem cell for use in regenerative medicine,” International Journal of Hematology-Oncology and Stem Cell Research, vol. 6, no. 1, pp. 1–5, 2012. View at Google Scholar · View at Scopus
  56. A. F. Cashen, B. Nervi, and J. DiPersio, “AMD3100: CXCR4 antagonist and rapid stem cell-mobilizing agent,” Future Oncology, vol. 3, no. 1, pp. 19–27, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. C. E. Edling and B. Hallberg, “c-Kit—a hematopoietic cell essential receptor tyrosine kinase,” International Journal of Biochemistry and Cell Biology, vol. 39, no. 11, pp. 1995–1998, 2007. View at Publisher · View at Google Scholar · View at Scopus